NCT05627518View on ClinicalTrials.gov

Relative Bioavailability of Linaprazan for the Test Formulation vs. Reference Formulation

PHASE1CompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

November 15, 2022

Primary Completion Date

December 30, 2022

Study Completion Date

January 3, 2023

Conditions
SafetyBioavailabilityPharmacokinetics
Interventions
DRUG

Linaprazan glurate

100 mg

Trial Locations (1)

1000

CRS d.o.o., Ljubljana

Sponsors
All Listed Sponsors
lead

Cinclus Pharma Holding AB

INDUSTRY